EVOK - Evoke Pharma GAAP EPS of $0.05 beats by $0.13 revenue of $0.36M misses by $0.15M March, 08 2022 04:34 PM Evoke Pharma Inc. Evoke Pharma press release (NASDAQ:EVOK): Q4 GAAP EPS of $0.05 beats by $0.13. Revenue of $0.36M (+1700.0% Y/Y) misses by $0.15M. For further details see: Evoke Pharma GAAP EPS of $0.05 beats by $0.13, revenue of $0.36M misses by $0.15M